Loomis, Sayles & Company’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02B | Buy |
1,941,070
+305,089
| +19% | +$160M | 1.28% | 17 |
|
|
2025
Q1 | $1.04B | Buy |
1,635,981
+60,632
| +4% | +$38.5M | 1.5% | 17 |
|
|
2024
Q4 | $1.12B | Buy |
1,575,349
+393,997
| +33% | +$281M | 1.42% | 17 |
|
|
2024
Q3 | $1.24B | Sell |
1,181,352
-35,504
| -3% | -$37.3M | 1.63% | 16 |
|
|
2024
Q2 | $1.28B | Buy |
1,216,856
+9,661
| +0.8% | +$10.2M | 1.76% | 16 |
|
|
2024
Q1 | $1.16B | Sell |
1,207,195
-11,872
| -1% | -$11.4M | 1.65% | 16 |
|
|
2023
Q4 | $1.07B | Sell |
1,219,067
-13,812
| -1% | -$12.1M | 1.64% | 16 |
|
|
2023
Q3 | $1.01B | Sell |
1,232,879
-44,605
| -3% | -$36.7M | 1.74% | 16 |
|
|
2023
Q2 | $918M | Sell |
1,277,484
-34,923
| -3% | -$25.1M | 1.48% | 17 |
|
|
2023
Q1 | $1.08B | Sell |
1,312,407
-25,274
| -2% | -$20.8M | 1.87% | 15 |
|
|
2022
Q4 | $965M | Sell |
1,337,681
-378,936
| -22% | -$273M | 1.93% | 17 |
|
|
2022
Q3 | $1.18B | Sell |
1,716,617
-48,171
| -3% | -$33.2M | 2.4% | 15 |
|
|
2022
Q2 | $1.04B | Sell |
1,764,788
-783,259
| -31% | -$463M | 1.94% | 17 |
|
|
2022
Q1 | $1.78B | Sell |
2,548,047
-81,104
| -3% | -$56.6M | 2.38% | 12 |
|
|
2021
Q4 | $1.66B | Sell |
2,629,151
-127,584
| -5% | -$80.6M | 2.01% | 14 |
|
|
2021
Q3 | $1.67B | Buy |
2,756,735
+2,511
| +0.1% | +$1.52M | 2.05% | 15 |
|
|
2021
Q2 | $1.54B | Sell |
2,754,224
-122,144
| -4% | -$68.2M | 1.86% | 18 |
|
|
2021
Q1 | $1.36B | Sell |
2,876,368
-88,215
| -3% | -$41.7M | 1.76% | 20 |
|
|
2020
Q4 | $1.43B | Sell |
2,964,583
-211,415
| -7% | -$102M | 1.89% | 19 |
|
|
2020
Q3 | $1.78B | Sell |
3,175,998
-83,700
| -3% | -$46.9M | 2.59% | 12 |
|
|
2020
Q2 | $2.03B | Sell |
3,259,698
-233,115
| -7% | -$145M | 3.26% | 9 |
|
|
2020
Q1 | $1.71B | Sell |
3,492,813
-199,862
| -5% | -$97.6M | 3.51% | 7 |
|
|
2019
Q4 | $1.39B | Buy |
3,692,675
+100,878
| +3% | +$37.9M | 2.36% | 11 |
|
|
2019
Q3 | $996M | Buy |
3,591,797
+311,476
| +9% | +$86.4M | 1.92% | 19 |
|
|
2019
Q2 | $1.03B | Buy |
3,280,321
+103,634
| +3% | +$32.4M | 1.92% | 18 |
|
|
2019
Q1 | $1.3B | Buy |
3,176,687
+15,540
| +0.5% | +$6.38M | 2.56% | 8 |
|
|
2018
Q4 | $1.18B | Sell |
3,161,147
-185,133
| -6% | -$69.1M | 2.79% | 7 |
|
|
2018
Q3 | $1.35B | Buy |
3,346,280
+41,138
| +1% | +$16.6M | 2.65% | 8 |
|
|
2018
Q2 | $1.14B | Buy |
3,305,142
+485,387
| +17% | +$167M | 2.31% | 11 |
|
|
2018
Q1 | $971M | Buy |
2,819,755
+718,144
| +34% | +$247M | 2.06% | 17 |
|
|
2017
Q4 | $790M | Buy |
2,101,611
+231,560
| +12% | +$87.1M | 1.64% | 21 |
|
|
2017
Q3 | $836M | Buy |
1,870,051
+47,755
| +3% | +$21.4M | 1.82% | 20 |
|
|
2017
Q2 | $895M | Buy |
1,822,296
+98,813
| +6% | +$48.5M | 2.11% | 11 |
|
|
2017
Q1 | $668M | Buy |
1,723,483
+8,178
| +0.5% | +$3.17M | 1.66% | 19 |
|
|
2016
Q4 | $630M | Buy |
1,715,305
+567,188
| +49% | +$208M | 1.55% | 23 |
|
|
2016
Q3 | $462M | Buy |
+1,148,117
| New | +$462M | 1.17% | 29 |
|
|
2014
Q1 | – | Sell |
-8,825
| Closed | -$2.43M | – | 769 |
|
|
2013
Q4 | $2.43M | Buy |
8,825
+1,019
| +13% | +$280K | 0.01% | 591 |
|
|
2013
Q3 | $2.44M | Buy |
7,806
+416
| +6% | +$130K | 0.01% | 571 |
|
|
2013
Q2 | $1.66K | Buy |
+7,390
| New | +$1.66K | 0.01% | 570 |
|